Cargando…

Lack of Association Between Cortical Amyloid Deposition and Glucose Metabolism in Early Stage Alzheimer´s Disease Patients

BACKGROUND: Beta amyloid (Aβ) causes synaptic dysfunction leading to neuronal death. It is still controversial if the magnitude of Aβ deposition correlates with the degree of cognitive impairment. Diagnostic imaging may lead to a better understanding the role of Aβ in development of cognitive defici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ehrlich, Daniela, Dunzinger, Andreas, Malsiner-Walli, Gertraud, Grün, Bettina, Topakian, Raffi, Hodolic, Marina, Kainz, Elmar, Pichler, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884854/ https://www.ncbi.nlm.nih.gov/pubmed/34957735 http://dx.doi.org/10.2478/raon-2021-0051

Ejemplares similares

Semi‐parametric Regression under Model Uncertainty: Economic Applications
por: Malsiner‐Walli, Gertraud, et al.
Publicado: (2019)

Model-based clustering based on sparse finite Gaussian mixtures
por: Malsiner-Walli, Gertraud, et al.
Publicado: (2014)

Identifying Mixtures of Mixtures Using Bayesian Estimation
por: Malsiner-Walli, Gertraud, et al.
Publicado: (2017)

How many data clusters are in the Galaxy data set?: Bayesian cluster analysis in action
por: Grün, Bettina, et al.
Publicado: (2021)

(18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy
por: Hodolic, Marina, et al.
Publicado: (2016)

From here to infinity: sparse finite versus Dirichlet process mixtures in model-based clustering
por: Frühwirth-Schnatter, Sylvia, et al.
Publicado: (2018)

Lack of LDL Receptor Enhances Amyloid Deposition and Decreases Glial Response in an Alzheimer's Disease Mouse Model
por: Katsouri, Loukia, et al.
Publicado: (2011)

Amyloid β deposition and glucose metabolism on the long-term progression of preclinical Alzheimer's disease
por: Hatashita, Shizuo, et al.
Publicado: (2019)

Somatostatin Receptor Subtype Expression in Patients with Acromegaly and Complicated Clinical Course
por: Pichler, Robert, et al.
Publicado: (2021)

Synergistic interaction between APOE and family history of Alzheimer’s disease on cerebral amyloid deposition and glucose metabolism
por: Yi, Dahyun, et al.
Publicado: (2018)

Cerebral venous and sinus thrombosis with complicating thromboangiitis obliterans
por: Einsiedler, Stefan, et al.
Publicado: (2021)

Thrombose des sinus veineux cérébraux compliquée par une thromboangéite oblitérante
por: Einsiedler, Stefan, et al.
Publicado: (2021)

The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Ling-Yun, et al.
Publicado: (2018)

Multitracer model for staging cortical amyloid deposition using PET imaging
por: Collij, Lyduine E., et al.
Publicado: (2020)

Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer’s disease, whereas amyloid deposition does not
por: Sang, Shaoming, et al.
Publicado: (2018)

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
por: Gordon, Brian A., et al.
Publicado: (2015)

Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementia
por: Ying, Chunwei, et al.
Publicado: (2023)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Measures of cortical microstructure are linked to amyloid pathology in Alzheimer’s disease
por: Spotorno, Nicola, et al.
Publicado: (2022)

ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
por: Button, Emily B., et al.
Publicado: (2019)

Association of Hippocampal Subfield Volumes with Amyloid-Beta Deposition in Alzheimer’s Disease
por: Baek, Min Seok, et al.
Publicado: (2022)

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease
por: Depp, Constanze, et al.
Publicado: (2023)

Parasagittal dural space hypertrophy and amyloid-β deposition in Alzheimer’s disease
por: Song, Alexander K, et al.
Publicado: (2023)

Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study
por: Kjeldsen, Pernille L., et al.
Publicado: (2022)

Cytomegalovirus Encephalitis Under Fingolimod Mimicking Progressive Multifocal Leukoencephalopathy?
por: Oel, Dierk, et al.
Publicado: (2021)

Brains from non-Alzheimer’s individuals containing amyloid deposits accelerate Aβ deposition in vivo
por: Duran-Aniotz, Claudia, et al.
Publicado: (2013)

In vivo evidence of cortical amyloid deposition in the adult form of Niemann Pick type C
por: Esposito, Marcello, et al.
Publicado: (2019)

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
por: Fagan, Anne M, et al.
Publicado: (2009)

Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
por: Saint-Aubert, Laure, et al.
Publicado: (2013)

Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition
por: Ishii, Kazunari, et al.
Publicado: (2014)

Proliferation in the Alzheimer Hippocampus Is due to Microglia, Not Astroglia, and Occurs at Sites of Amyloid Deposition
por: Marlatt, Michael W., et al.
Publicado: (2014)

Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient
por: Chilumuri, Amrutha, et al.
Publicado: (2013)

Progranulin haploinsufficiency reduces amyloid beta deposition in Alzheimer’s disease model mice
por: Hosokawa, Masato, et al.
Publicado: (2017)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition
por: Leonenko, Ganna, et al.
Publicado: (2019)

Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk
por: Salih, Dervis A, et al.
Publicado: (2019)

N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer’s disease
por: Zampar, S., et al.
Publicado: (2020)

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease
por: Espinoza, Sandra, et al.
Publicado: (2022)

Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline
por: Mehta, Neel H., et al.
Publicado: (2023)

Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease
por: Bischof, Gérard N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cb8dprjjoer3f68071g04203dv